Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.06% Nasdaq Down0.69%

Hi-Tech Pharmacal Co., Inc. (HITK)

43.49 Down 0.01(0.02%) Apr 16 - Nasdaq Real Time Price
Get the big picture on all your investments.
ProfileGet Profile for:
Hi-Tech Pharmacal Co., Inc.
369 Bayview Avenue
Amityville, NY 11701
United States - Map
Phone: 631-789-8228
Fax: 631-789-8429

Index Membership:N/A
Industry:Drugs - Generic
Full Time Employees:447

Business Summary 

Hi-Tech Pharmacal Co., Inc., a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription, and over-the-counter (OTC) products in the United States. It operates in three segments: Generic Pharmaceuticals, OTC Branded Pharmaceuticals, and Prescription Brands. The company manufactures liquid and semi-solid dosage forms; and produces a range of sterile ophthalmic, otic, and inhalation products. Its generic products include oral solutions and suspensions, topical creams, and ointments, as well as nasal sprays. Hi-Tech Pharmacal Co. also markets OTC branded products, such as Diabetic Tussin, DiabetiDerm, Multi-betic, Mag-Ox, Choice DM, and DiabetiSweet primarily for people with diabetes; capsaicin products under the Zostrix brand name for pain management of conditions comprising arthritis and foot pain; Nasal Ease homeopathic allergy reliever; and Sinus Buster homeopathic sinus congestion reliever. In addition, the company markets and distributes branded prescription products to treat various disease states, including pain, cough/cold and allergies, contact dermatitis, sleep disorders, and swimmer’s ear. It serves chain drug stores, drug wholesalers, managed care purchasing organizations, federal government agencies, generic distributors, mass merchandisers, and mail order pharmacies. The company was founded in 1982 and is based in Amityville, New York. As of April 17, 2014, Hi-Tech Pharmacal Co., Inc. operates as a subsidiary of Akorn, Inc.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Hi-Tech Pharmacal Co., Inc.

Corporate Governance 
Hi-Tech Pharmacal Co., Inc.’s ISS Governance QuickScore as of Apr 1, 2014 is 9. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 2; Compensation: 10.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Mr. David S. Seltzer , 54
Chairman, Chief Exec. Officer, Pres, Sec. and Treasurer
Mr. William J. Peters , 46
Chief Financial Officer and VP of Fin.
Mr. Kamel Egbaria Ph.D., 56
Chief Scientific Officer and Exec. VP
Dr. Cameron Durrant M.D., MBA, 53
Chief Exec. Officer of ECR Pharmaceuticals and Pres of ECR Pharmaceuticals
Mr. Eyal Mares , 51
VP of Operations
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders